Skip to main content
Log in

Extended DAPT cost effective after DES for ACS

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

Reference

  • Jiang M, et al. Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome. Clinical Cardiology : 6 Jul 2017. Available from: URL: http://doi.org/10.1002/clc.22756

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Extended DAPT cost effective after DES for ACS. PharmacoEcon Outcomes News 783, 17 (2017). https://doi.org/10.1007/s40274-017-4188-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4188-0

Navigation